OMV-based vaccines for SARS-CoV-2

Picture source: Dr. Matt Delisa, Locally Sourced Science The development, production, and manufacturing of large-scale vaccines are necessary for control of the pandemic internationally- to divide the load as well as keep vaccines up to date with the emerging variants- especially in underdeveloped countries. The vaccination has turned into a race between SARS-CoV-2 and scientists,Continue reading OMV-based vaccines for SARS-CoV-2

SARS-CoV2 Mu variant is resistant towards serum antibody neutralization

Picture source: 11Alive It is no news, vaccination against SARS-CoV-2 enormously decreases chances of severe side effects and hospitalizations, but vaccinated individuals are still not spared in this pandemic. This is mainly because of the rare breakthrough cases being reported by vaccinated people mostly caused by the newer SARS-CoV-2 strains. As of September 2021, thereContinue reading “SARS-CoV2 Mu variant is resistant towards serum antibody neutralization”

SARS-COV-2 Delta Variant: The Uninvited Guest and How to Deal with it.

Picture source: WHO SARS-CoV-2 is an RNA virus- ergo it was expected to mutate. Unfortunately, about 163 million Americans had already gotten the shot before the new Delta (B.1.617.2) variant emerged. This new variant, first identified in India, was seen to be much more contagious than the previous versions. The spreading of misinformation in publicContinue reading “SARS-COV-2 Delta Variant: The Uninvited Guest and How to Deal with it.”